The anticancer thiosemicarbazones Dp44mT and triapine lack inhibitory effects as catalytic inhibitors or poisons of DNA topoisomerase IIα - ScienceDirect
Nanoformulations of anticancer thiosemicarbazones to reduce methemoglobin formation and improve anticancer activity - RSC Advances (RSC Publishing) DOI:10.1039/C6RA07659A
![B3209-10mg | Triapine [236392-56-6; 200933-27-3; 143621-35-6] Clinisciences](https://www.apexbt.com/pub/media/prod_images/b/3/b3209.png "B3209-10mg | Triapine [236392-56-6; 200933-27-3; 143621-35-6] Clinisciences")
B3209-10mg | Triapine [236392-56-6; 200933-27-3; 143621-35-6] Clinisciences
Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair | British Journal of Cancer
Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
PDF) Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine | Elizabeth Eisenhauer and Bakul Dalal - Academia.edu
Induction of different cell death characteristics by Triapine and Me 2... | Download Scientific Diagram
RRM2 inhibition using triapine selectively kills GBM cells and... | Download Scientific Diagram
Chemical structures of the chelators, Triapine, di-2-pyridylketone... | Download Scientific Diagram
RRM2 inhibition using triapine selectively kills GBM cells and... | Download Scientific Diagram
Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick
Impact of Stepwise NH2-Methylation of Triapine on the Physicochemical Properties, Anticancer Activity, and Resistance Circumvention | Journal of Medicinal Chemistry
Activity and electrochemical properties: iron complexes of the anticancer drug triapine and its analogs | SpringerLink
3-AP (PAN-811) | Ribonucleotide Reductase Inhibitor | MedChemExpress
Triapine | CAS:236392-56-6 | Ribonucleotide reductase inhibitor | High Purity | Manufacturer BioCrick
Frontiers | Triapine Radiochemotherapy in Advanced Stage Cervical Cancer
Triapine potentiates platinum-based combination therapy by disruption of homologous recombination repair | British Journal of Cancer
Triapine Analogues and Their Copper(II) Complexes: Synthesis, Characterization, Solution Speciation, Redox Activity, Cytotoxicity, and mR2 RNR Inhibition | Inorganic Chemistry
Biomolecules | Free Full-Text | Triapine Derivatives Act as Copper Delivery Vehicles to Induce Deadly Metal Overload in Cancer Cells | HTML
adverse events by grade with any relationship to triapine-... | Download Table
3 Aminopicolinaldehyde Thiosemicarbazone - an overview | ScienceDirect Topics
Frontiers | Phase I Trial of Triapine–Cisplatin–Paclitaxel Chemotherapy for Advanced Stage or Metastatic Solid Tumor Cancers
Twenty-first century cervical cancer management: A historical perspective of the gynecologic oncology group/NRG oncology over the past twenty years - Gynecologic Oncology
Current and Future Initiatives for Radiation Oncology at the National Cancer Institute in the Era of Precision Medicine - International Journal of Radiation Oncology, Biology, Physics
Phase II study of 3-AP Triapine in patients with recurrent or metastatic head and neck squamous cell carcinoma - Annals of Oncology
PDF) Fluorescence properties and cellular distribution of the investigational anticancer drug Triapine (3-aminopyridine-2-carboxaldehyde thiosemicarbazone) and its zinc(II) complex
Cytostatic activity of KP772 in comparison with Triapine and HU. A549... | Download Scientific Diagram
